- Specialities Breast Surgery, Oncoplastic Surgery, Oncology
- Telephone 07722275780
- Year of first qualification 1995
- Email email@example.com
- GMC Number 5201586
- Fax 01890 230340
Mr Haresh Devalia was certified as "Best Student at National Level in General Surgery" (August 1997) and was awarded a Gold Medal in the final examination for the Diploma of National Board, India.
Mr Devalia commenced higher surgical training in Oxford Deanery and continued as a specialist registrar in Southwest Thames surgical rotation in the London Deanery. He was trained at various hospitals including St George's Hospital (London), Ashford and St Peter's Hospital (Chertsey), the Royal Marsden Hospital (Sutton).
After completion of his training, he was appointed as a locum Consultant Breast and Oncoplastic surgeon at the Royal Surrey County Hospital (Guilford) and the Royal Marsden Hospital before substantive appointment at Maidstone and Tunbridge Wells NHS Trust as a Consultant Breast Oncoplastic Surgeon.
Presently, Mr Devalia leads breast cancer team and chairs the multidisciplinary team at the Maidstone and Tunbridge Wells Hospital.
- Weekly Monday AM
- Consultant Breast and Oncoplastic Surgeon, Maidstone and Tunbridge Wells Hospital
- Breast cancer lead and MDT Chair
Mr Devalia's main clinical interests lie in the field of breast surgery including the early detection of breast cancer, minimal, access breast surgery, the sentinel node biospy, skin-sparing mastectomy and immediate breast reconstruction, delayed reconstruction, breast enlargement, breast reduction, mastopexy and nipple reconstruction. He also performs breast lipomodelling (fat transfer).
Golf and swimming.
- British Medical Association
- Royal College of Surgeons (Ed)
- British Association of Surgical Oncologists
Mr Devalia has published in various peer-reviewed and international literatures. He carries out his research at London Research Institute on oncological safety of preserving the skin envelope in patients undergoing mastectomy and immedicate breast reconstruction for breast cancer. It was subsequently evaluated by a prospective patient survey which showed extremely high statisfaction.